Increased circulating concentrations and augmented myocardial extraction of osteoprotegerin in heart failure due to left ventricular pressure overload

European Journal of Heart Failure

Volumn 9, Issue 4, 2007, Pages 357-363

  Helske, Satu ^a   Kovanen, Petri T ^a   Lindstedt, Ken A ^a   Salmela, Kaija ^b   Lommi, Jyri ^b   Turto, Heikki ^b   Werkkala, Kalervo ^b   Kupari, Markku ^b  

^a WIHURI RESEARCH INSTITUTE   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Aortic stenosis; Heart failure; Osteoprotegerin

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ADULT; AGED; AORTA ROOT; AORTA STENOSIS; ARTICLE; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CORONARY SINUS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMORAL VEIN; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE BIOPSY; HEART VALVE REPLACEMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; IMMUNOENZYME TECHNIQUES; MALE; MYOCARDIUM; OSTEOPROTEGERIN; PILOT PROJECTS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RISK FACTORS;

EID: 33947331531     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2006.10.015     Document Type: Article

References (19)

1. Lacey D.L., Timms E., Tan H.L., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 (1998) 165-176
2. Hsu H., Lacey D.L., Dunstan C.R., et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A 96 (1999) 3540-3545
3. Emery J.G., McDonnell P., Burke M.B., et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem 273 (1998) 14363-14367
4. Yun T.J., Tallquist M.D., Aicher A., et al. Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function. J Immunol 166 (2001) 1482-1491
5. Bucay N., Sarosi I., Dunstan C.R., et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12 (1998) 1260-1268
6. Dhore C.R., Cleutjens J.P., Lutgens E., et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 21 (2001) 1998-2003
7. Schoppet M., Sattler A.M., Schaefer J.R., Herzum M., Maisch B., and Hofbauer L.C. Increased osteoprotegerin serum levels in men with coronary artery disease. J Clin Endocrinol Metab 88 (2003) 1024-1028
8. Jono S., Ikari Y., Shioi A., et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 106 (2002) 1192-1194
9. Kiechl S., Schett G., Wenning G., et al. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation 109 (2004) 2175-2180
10. Browner W.S., Lui L.Y., and Cummings S.R. Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab 86 (2001) 631-637
11. Ueland T., Jemtland R., Godang K., et al. Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction. J Am Coll Cardiol 44 (2004) 1970-1976
12. Ueland T., Yndestad A., Oie E., et al. Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure. Circulation 111 (2005) 2461-2468
13. Schoppet M., Ruppert V., Hofbauer L.C., et al. TNF-related apoptosis-inducing ligand and its decoy receptor osteoprotegerin in nonischemic dilated cardiomyopathy. Biochem Biophys Res Commun 338 (2005) 1745-1750
14. Kupari M., Turto H., and Lommi J. Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure?. Eur Heart J 26 (2005) 1790-1796
15. Devereux R.B., Lutas E.M., Casale P.N., et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 4 (1984) 1222-1230
16. Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
17. Kupari M., Turto H., and Lommi J. Diagnosing heart failure in aortic valve stenosis. J Intern Med 256 (2004) 381-387
18. Helske S., Lindstedt K.A., Laine M., et al. Induction of local angiotensin II-producing systems in stenotic aortic valves. J Am Coll Cardiol 44 (2004) 1859-1866
19. Moran C.S., McCann M., Karan M., Norman P., Ketheesan N., and Golledge J. Association of osteoprotegerin with human abdominal aortic aneurysm progression. Circulation 111 (2005) 3119-3125